Rentabilitas dodolan miturut bathi resik ImmunoPrecise Antibodies (IPA)

Lambang korporat lan logo ImmunoPrecise Antibodies Ltd (IPA)

ImmunoPrecise Antibodies (IPA) is accelerating the development of biologics through innovative antibody discovery. The target net margin demonstrates effective cost management, with the -122.10 mark reflecting the current state. While robotics and AI screening are replacing manual labor, competitive pressure and a decline in external research orders create certain risks for the company's bottom line.

ImmunoPrecise Antibodies Ltd. (IPA) - Margin dodolan resik saka 04.07.2022 nganti 04.09.2025

immunoprecise.com - rincian analitis lan metrik utama (IPA)

- rega saham lan prakiraan rega para ahli:
Analisis kabeh metrik perusahaan:ImmunoPrecise Antibodies - IPA
Produk dadi ImmunoPrecise Antibodies

This indicator serves as a key filter to separate temporary fluctuations from the asset's long-term potential. The metric calculates the share of net profit in total revenue, reflecting the actual efficiency of business monetization. By analyzing the sales margin level, an investor determines the capital's resilience to market recessions. Growth in these indicators confirms a high return on investment in advanced laboratories. The loyalty of antibody engineering experts converts directly into the operating profitability of ImmunoPrecise Antibodies (IPA).

Pesaing langsung

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|FDMT - Margin dodolan resik|LXEO: Margin dodolan resik|Korro Bio Inc. - Tingkat bathi resik|EDIT (editasmedicine.com) - Margin dodolan resik|Margin resik SLN|Margin resik ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan resik|Margin resik Sangamo SGMO|NAUT: Rentabilitas dodolan resik|MGX: Rentabilitas dodolan miturut bathi resik|Margin resik Precision BioSciences|GBIO (generationbio.com) - Rentabilitas dodolan miturut bathi resik|Margin resik boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Margin dodolan resik|Rentabilitas dodolan resik IMNN (Imunon, Inc.)|Margin dodolan resik PHIO|MBIO - Margin resik|Margin dodolan resik RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Margin resik|Applied DNA - Margin dodolan resik|Margin resik Bluebird Bio|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX